What is Stelara?

Category: Prescription Drugs

true

Generic name: Ustekinumab

Stelara is a brand of ustekinumab, an antipsoriatic agent, monoclonal antibody. It is used in the treatment of moderate to severe plaque psoriasis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 8
None 22

Commonly reported side effects and conditions associated with Stelara

Side effect Patients
Headaches 3
Achiness 1
Bronchiectasis 1
Excessive dry mouth 1
Fatigue 1
Immune system weak 1

Show all 9 reported side effects

Dosages

Based on patients currently taking Stelara

Dosage Patients
90 mg every 3 months 3
45 mg every 3 months 2
1 mg every 3 months 1
1 other every 3 months 1
1 other monthly 1
45 mg every 12 weeks 1

Why patients stopped taking Stelara

Multiple reasons could be selected

Reason Patients
Did not seem to work 5
Course of treatment ended 2
Doctor's advice 2
Other 2
Side effects too severe 1
See all 8 patients who’ve stopped taking Stelara

Duration

Currently taking Stelara

Duration Patients
1 - 2 years 1
2 - 5 years 6
5 - 10 years 2

Stopped taking Stelara

Duration Patients
1 - 6 months 3
6 months - 1 year 4
2 - 5 years 1
Adherence
Adherence Evaluations
Always 29
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 3
Not at all hard to take 25
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 6
$25-49 2
< $25 17
Not specified 4

What people switch to and from

Patients started taking Stelara after stopping:

Treatment Patients
Adalimumab (Humira Pen) 2
Clobetasol topical (Clobex) 1
Etanercept (Enbrel SureClick) 1
Hydrocortisone topical (Cortizone-10) 1
Infliximab (Remicade) 1

Patients stopped taking Stelara and switched to:

Treatment Patients
Secukinumab (Cosentyx) 1
Last updated:
There are no evaluations for Stelara.